NEW YORK, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing ...
BIO-key ® International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced its first quarter (Q1’26) results and ...
Management of complex quality control (QC) data is essential to insure high quality patient care and maintain regulatory compliance within clinical laboratories. Robust software solutions for ...
Intelligent Bio Solutions Inc. closed a $3.0 million public offering of 1.5 million shares at $2.00 each. Intelligent Bio Solutions Inc. has successfully completed an underwritten public offering, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results